## CLX: The Clorox Company - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 -1.9% below STRENGTH zone (4.0-10.0%); PEG 3.19 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($100.12)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Neutral (Bullish: 2, Bearish: 0)

**1. Is Clorox Offering Value After a 35% Slide and DCF Upside in 2025?**
- Source: Simply Wall Street | 20251204T125426 | Somewhat-Bullish | Relevance: 100%
- Clorox has seen a 35% year-to-date stock slide, prompting questions about its valuation. A Discounted Cash Flow (DCF) analysis suggests Clorox is significantly undervalued by over 50.8%, estimating its intrinsic value at approximately $213.56 per share compared to its current price around $105. However, its Price to Earnings (PE) ratio of 16.2x is very close to its proprietary Fair Ratio of 16.1x, indicating the market is pricing it in line with its fundamentals based on this metric.

**2. Hidden Valley Ranch brings digital recipe success full funnel**
- Source: The Clorox Company | 20251205T210823 | Bullish | Relevance: 100%
- Hidden Valley Ranch is expanding its recipe-driven approach to include TV advertising, aiming to boost brand relevance for popular meal occasions. By using AI to create multiple versions of recipe videos from a single shoot, the company can scale quickly and cost-effectively, aligning content with cultural moments. This strategy, part of the broader IGNITE initiative, transforms recipes from a digital-first tactic into a cross-channel approach to drive business results.

**3. American Century Companies Inc. Has $9.91 Million Position in The Clorox Company $CLX**
- Source: MarketBeat | 20251205T090921 | Neutral | Relevance: 100%
- American Century Companies Inc. reduced its stake in The Clorox Company (NYSE:CLX) by 26.4% in the second quarter, now holding 82,556 shares valued at $9.91 million. Despite this, other institutional investors like Nomura Asset Management and Nuance Investments significantly increased their positions, indicating varied institutional sentiment. The article also covers recent insider buying, Clorox's financial performance, dividend announcements, and current analyst ratings.

**4. Groupe la Francaise Takes Position in The Clorox Company $CLX**
- Source: MarketBeat | 20251204T220828 | Somewhat-Bearish | Relevance: 100%
- Groupe la Francaise acquired a new stake of 26,876 shares, valued at approximately $3.21 million, in The Clorox Company during the second quarter. Clorox reported earnings per share of $0.85, beating estimates, but revenue decreased by 18.9% year-over-year. Analysts have largely trimmed price targets, with an average "Reduce" rating and a target of $125.69, while the company announced a quarterly dividend of $1.24 per share.

**5. Norges Bank Makes New Investment in The Clorox Company $CLX**
- Source: MarketBeat | 20251203T121232 | Somewhat-Bearish | Relevance: 100%
- Norges Bank has made a significant new investment in The Clorox Company, purchasing over 1.5 million shares valued at approximately $190.4 million during Q2, representing about 1.29% of the company. This comes as Clorox reported Q2 earnings of $0.85 EPS, exceeding expectations, but with an 18.9% revenue decline year-over-year and forward guidance below analyst estimates. The company declared a quarterly dividend of $1.24, resulting in a 4.7% yield, while analysts generally hold a "Reduce" rating with an average target price of $125.69.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 12 ($10.20M) |
| Sells | 11 ($0.63M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 12.9% (-0.7%)
- Blackrock Inc.: 8.5% (-1.2%)
- State Street Corpora: 6.9% (+3.5%)
- Invesco Ltd.: 3.3% (+23.1%)
- Morgan Stanley: 2.6% (+18.3%)

### Key Risks

1. Valuation stretched: PEG 3.2x requires aggressive growth execution.
2. Long-term trend broken: trading 17.7% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.19 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 44%, ROA 12%). Insider buying signal ($10.2M), management confidence. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $12.0B |
| Beta | 0.57 |
| 52W Range | $96.66 - $164.41 |
| Short Interest | 6.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.19 |
| Forward P/E | 15.5 |
| Current P/E | 17.5 |
| YoY Growth | 12.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 0.2% to -1.9% (-2.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.8pp (needs >4.0% for momentum thesis). Below SMA200 (0.82x), long-term trend not supportive. MACD histogram positive (0.70), confirming momentum. RSI neutral at 42. OFD pattern: +DUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.85% (CS: 38) | Neutral |
| RSI_14 | 42.1 | Neutral |
| MACD Histogram | 0.70 | Bullish |
| vs SMA20 | 1.004x | Above |
| vs SMA50 | 0.934x | Below |
| vs SMA200 | 0.823x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $104.90
- **Stop Loss:** $100.12 (4.6% risk)
- **Target:** $109.68 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 104
- **Position Value:** $10,909.60
- **Portfolio %:** 10.91%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-03 (Est: $1.45)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.78 | $0.85 | +9.2% |
| 2025Q2 | $2.21 | $2.87 | +29.8% |
| 2025Q1 | $1.56 | $1.45 | -6.9% |
| 2024Q4 | $1.40 | $1.55 | +10.7% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*